These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 21038843)
1. The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles. Ozturk K; Caban S; Kozlu S; Kadayifci E; Yerlikaya F; Capan Y Pharmazie; 2010 Sep; 65(9):665-9. PubMed ID: 21038843 [TBL] [Abstract][Full Text] [Related]
2. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Budhian A; Siegel SJ; Winey KI Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944 [TBL] [Abstract][Full Text] [Related]
3. Novel one-pot facile technique for preparing nanoparticles modified with hydrophilic polymers on the surface via block polymer-assisted emulsification/evaporation process. Kanakubo Y; Ito F; Murakami Y Colloids Surf B Biointerfaces; 2010 Jun; 78(1):85-91. PubMed ID: 20223642 [TBL] [Abstract][Full Text] [Related]
4. Preparation and physicochemical characterization of naproxen-PLGA nanoparticles. Javadzadeh Y; Ahadi F; Davaran S; Mohammadi G; Sabzevari A; Adibkia K Colloids Surf B Biointerfaces; 2010 Dec; 81(2):498-502. PubMed ID: 20719477 [TBL] [Abstract][Full Text] [Related]
5. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release. Saxena V; Sadoqi M; Shao J Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634 [TBL] [Abstract][Full Text] [Related]
7. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design. Zhou YZ; Alany RG; Chuang V; Wen J Drug Dev Ind Pharm; 2013 Feb; 39(2):321-30. PubMed ID: 22607101 [TBL] [Abstract][Full Text] [Related]
8. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related]
9. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery. Katas H; Cevher E; Alpar HO Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405 [TBL] [Abstract][Full Text] [Related]
10. Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles. Kuo YC; Yu HW Colloids Surf B Biointerfaces; 2011 May; 84(1):253-8. PubMed ID: 21288700 [TBL] [Abstract][Full Text] [Related]
11. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles. Niu X; Zou W; Liu C; Zhang N; Fu C Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638 [TBL] [Abstract][Full Text] [Related]
12. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Win KY; Feng SS Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275 [TBL] [Abstract][Full Text] [Related]
13. Effect of microfluidization parameters on the physical properties of PEG-PLGA nanoparticles prepared using high pressure microfluidization. Sani SN; Das NG; Das SK J Microencapsul; 2009 Sep; 26(6):556-61. PubMed ID: 18946802 [TBL] [Abstract][Full Text] [Related]
14. Mixture designs in the optimisation of PLGA nanoparticles: influence of organic phase composition on β-aescin encapsulation. Ven HV; Vandervoort J; Weyenberg W; Apers S; Ludwig A J Microencapsul; 2012; 29(2):115-25. PubMed ID: 22047548 [TBL] [Abstract][Full Text] [Related]
15. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method. Choi SH; Park TG Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477 [TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells. Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410 [TBL] [Abstract][Full Text] [Related]
17. Preparation factors affecting the properties of polylactide nanoparticles: a factorial design study. Vandervoort J; Ludwig A Pharmazie; 2001 Jun; 56(6):484-8. PubMed ID: 11446170 [TBL] [Abstract][Full Text] [Related]
18. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method. Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303 [TBL] [Abstract][Full Text] [Related]
19. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization. Surassmo S; Saengkrit N; Ruktanonchai UR; Suktham K; Woramongkolchai N; Wutikhun T; Puttipipatkhachorn S Colloids Surf B Biointerfaces; 2015 Jun; 130():229-36. PubMed ID: 25937384 [TBL] [Abstract][Full Text] [Related]
20. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]